4D Molecular
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 7/22/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (9)
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Started: 7/22/2025
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Started: 3/3/2025
4D-150 in Patients With Diabetic Macular Edema
Started: 8/9/2023
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Started: 12/9/2021
4D-310 in Adults With Fabry Disease and Cardiac Involvement
Started: 10/16/2022
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
Started: 6/2/2020
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
Started: 6/9/2020
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
Started: 9/1/2020